Showing results (111-120 of 319) with videos related to

Sort By:
Pageof 32
International Journal of Molecular Sciences|February 15, 2022
THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair InhibitorsPavithra Shyamsunder, Shree Pooja Sridharan, Vikas Madan, et al.
American Journal of Medical Genetics. Part A|February 26, 2004
Characterization of breakpoints in the GABRG3 and TSPY genes in a family with a t(Y;15)(p11.2;q12)Leena Gole, John A Crolla, Simon N Thomas, et al.
Fetal Diagnosis and Therapy|May 28, 2008
Prenatal detection of isochromosome 21 by QF-PCR. A comparison between FISH and traditional karyotypingLeena Gole, Ng Bee Lian, Ng Poh Lian, et al.
Prenatal Diagnosis|April 3, 2012
Same-day prenatal diagnosis of common chromosomal aneuploidies using microfluidics-fluorescence in situ hybridizationSherry S Y Ho, Cuiwen Chua, Leena Gole, et al.
Blood|July 8, 2011
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AMLJianbiao Zhou, Chonglei Bi, Lip-Lee Cheong, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2013
Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancerDaniel Chan, Yun Zheng, Jeffrey W Tyner, et al.
Ejhaem|December 5, 2022
Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trialAndrew Spencer, Olga Samoilova, Wee-Joo Chng, et al.
Open Forum Infectious Diseases|July 17, 2015
Necrotizing Fasciitis in Hematological Patients: Enterobacteriaceae Predominance and Limited Utility of Laboratory Risk Indicator for Necrotizing Fasciitis ScoreRui Min Foo, Moon Ley Tung, Li Mei Poon, et al.
Blood|November 15, 2014
Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myelomaShaji K Kumar, Betsy LaPlant, Wee Joo Chng, et al.
Nature Communications|March 22, 2024
Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myelomaDaniel A Ang, Jean-Michel Carter, Kamalakshi Deka, et al.
Pageof 32